Bilaketaren emaitzak - Elizaveta S. Leshchiner
- Erakusten 1 - 10 emaitzak -- 10
-
1
Direct activation of full-length proapoptotic BAK nork Elizaveta S. Leshchiner, Craig R. Braun, Geoffrey Bird, Loren D. Walensky
Argitaratua 2013Artigo -
2
-
3
-
4
-
5
-
6
Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver nork Akin Akinc, Michael S. Goldberg, June Qin, J. Robert Dorkin, Christina Gamba‐Vitalo, Martin A. Maier, K. N. Jayaprakash, Muthusamy Jayaraman, Kallanthottathil G. Rajeev, Muthiah Manoharan, Victor Koteliansky, Ingo Röhl, Elizaveta S. Leshchiner, Róbert Langer, Daniel G. Anderson
Argitaratua 2009Artigo -
7
Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease nork Elizaveta S. Leshchiner, Jason S. Rush, Michael A. Durney, Zhifang Cao, Vlado Dančík, Benjamin Chittick, Huixian Wu, Adam Petrone, Joshua A. Bittker, Andrew J. Phillips, José R. Perez, Alykhan F. Shamji, Virendar K. Kaushik, Mark J. Daly, Daniel B. Graham, Stuart L. Schreiber, Ramnik J. Xavier
Argitaratua 2017Artigo -
8
Ubiquitin Ligase TRIM62 Regulates CARD9-Mediated Anti-fungal Immunity and Intestinal Inflammation nork Zhifang Cao, Kara L. Conway, Robert J. W. Heath, Jason S. Rush, Elizaveta S. Leshchiner, Zaida G. Ramirez‐Ortiz, Natalia B. Nedelsky, Hailiang Huang, Aylwin Ng, Agnès Gardet, Shih‐Chin Cheng, Alykhan F. Shamji, John D. Rioux, Cisca Wijmenga, Mihai G. Netea, Terry K. Means, Mark J. Daly, Ramnik J. Xavier
Argitaratua 2015Artigo -
9
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis nork Yilong Zou, Michael J. Palte, Amy Deik, Haoxin Li, John K. Eaton, Wenyu Wang, Yuen‐Yi Tseng, Rebecca Deasy, Maria Kost‐Alimova, Vlado Dančík, Elizaveta S. Leshchiner, Vasanthi S. Viswanathan, Sabina Signoretti, Toni K. Choueiri, Jesse S. Boehm, Bridget K. Wagner, John G. Doench, Clary B. Clish, Paul A. Clemons, Stuart L. Schreiber
Argitaratua 2019Artigo -
10
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics nork Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg, Elizaveta S. Leshchiner, Valentina Busini, Naushad Hossain, Sergio Bacallado, David N. Nguyen, Jason Fuller, Rene Alvarez, Anna Borodovsky, Todd Borland, Rainer Constien, Antonin de Fougerolles, J. Robert Dorkin, K. N. Jayaprakash, Muthusamy Jayaraman, Matthias John, Victor Koteliansky, Muthiah Manoharan, Lubomir V. Nechev, June Qin, Timothy Racie, Denitza Raitcheva, Kallanthottathil G. Rajeev, Dinah W.Y. Sah, Jürgen Soutschek, Ivanka Toudjarska, Hans‐Peter Vornlocher, Tracy Zimmermann, Róbert Langer, Daniel G. Anderson
Argitaratua 2008Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Biology
Gene
Biochemistry
Cell biology
Chemistry
Apoptosis
Enzyme
Genetics
Programmed cell death
RNA
RNA interference
Bcl-2-associated X protein
Biotechnology
Cancer research
Caspase 3
Cell cycle
Computational biology
Drug delivery
Gene silencing
Immunology
In vitro
In vivo
Mitochondrion
Mutant
Organic chemistry
Small interfering RNA
Activator (genetics)
Bcl-2 family
Bioinformatics
Biophysics